Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
Yonsei Medical Journal
;
: 196-198, 2011.
Artigo
em Inglês
| WPRIM
| ID: wpr-136362
ABSTRACT
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of complete atrioventricular block while receiving bortezomib. We immediately stopped bortezomib, and after inserting a permanent VDD pacemaker, the patients' symptoms disappeared.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pirazinas
/
Ácidos Borônicos
/
Bloqueio Atrioventricular
/
Mieloma Múltiplo
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Yonsei Medical Journal
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS